These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 16822701

  • 1. Streamlining lead discovery by aligning in silico and high-throughput screening.
    Davies JW, Glick M, Jenkins JL.
    Curr Opin Chem Biol; 2006 Aug; 10(4):343-51. PubMed ID: 16822701
    [Abstract] [Full Text] [Related]

  • 2. Novel trends in high-throughput screening.
    Mayr LM, Bojanic D.
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [Abstract] [Full Text] [Related]

  • 3. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM, Schurdak ME.
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [Abstract] [Full Text] [Related]

  • 4. Virtual screening strategies in drug discovery.
    McInnes C.
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [Abstract] [Full Text] [Related]

  • 5. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T, Krovat EM.
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [Abstract] [Full Text] [Related]

  • 6. Smart screening: approaches to efficient HTS.
    Engels MF, Venkatarangan P.
    Curr Opin Drug Discov Devel; 2001 May; 4(3):275-83. PubMed ID: 11560058
    [Abstract] [Full Text] [Related]

  • 7. Using computational techniques in fragment-based drug discovery.
    Desjarlais RL.
    Methods Enzymol; 2011 May; 493():137-55. PubMed ID: 21371590
    [Abstract] [Full Text] [Related]

  • 8. High-content screening moves to the front of the line.
    Haney SA, LaPan P, Pan J, Zhang J.
    Drug Discov Today; 2006 Oct; 11(19-20):889-94. PubMed ID: 16997138
    [Abstract] [Full Text] [Related]

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 10. High-throughput screening-driven lead discovery: meeting the challenges of finding new therapeutics.
    Posner BA.
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):487-94. PubMed ID: 16022185
    [Abstract] [Full Text] [Related]

  • 11. Selection criteria for drug-like compounds.
    Muegge I.
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [Abstract] [Full Text] [Related]

  • 12. From targets to leads: the importance of advanced data analysis for decision support in drug discovery.
    Fischer HP, Heyse S.
    Curr Opin Drug Discov Devel; 2005 May; 8(3):334-46. PubMed ID: 15892249
    [Abstract] [Full Text] [Related]

  • 13. HTS technologies in biopharmaceutical discovery.
    Wu G, Doberstein SK.
    Drug Discov Today; 2006 Aug; 11(15-16):718-24. PubMed ID: 16846799
    [Abstract] [Full Text] [Related]

  • 14. High-throughput siRNA-based functional target validation.
    Xin H, Bernal A, Amato FA, Pinhasov A, Kauffman J, Brenneman DE, Derian CK, Andrade-Gordon P, Plata-Salamán CR, Ilyin SE.
    J Biomol Screen; 2004 Jun; 9(4):286-93. PubMed ID: 15191645
    [Abstract] [Full Text] [Related]

  • 15. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP, Horvath CR, Stout SJ, Kenney KL, Ho PI, Zhang JH, Vickers C, Kaushik V, Hubbard B, Wang YK.
    Anal Chem; 2007 Nov 01; 79(21):8207-13. PubMed ID: 17902631
    [Abstract] [Full Text] [Related]

  • 16. Hit and lead generation: beyond high-throughput screening.
    Bleicher KH, Böhm HJ, Müller K, Alanine AI.
    Nat Rev Drug Discov; 2003 May 01; 2(5):369-78. PubMed ID: 12750740
    [Abstract] [Full Text] [Related]

  • 17. The role of computational methods in the identification of bioactive compounds.
    Glick M, Jacoby E.
    Curr Opin Chem Biol; 2011 Aug 01; 15(4):540-6. PubMed ID: 21411361
    [Abstract] [Full Text] [Related]

  • 18. High content cellular screening.
    Rausch O.
    Curr Opin Chem Biol; 2006 Aug 01; 10(4):316-20. PubMed ID: 16793326
    [Abstract] [Full Text] [Related]

  • 19. Fragment-based lead discovery: a chemical update.
    Erlanson DA.
    Curr Opin Biotechnol; 2006 Dec 01; 17(6):643-52. PubMed ID: 17084612
    [Abstract] [Full Text] [Related]

  • 20. HTS techniques to investigate the potential effects of compounds on cardiac ion channels at early-stages of drug discovery.
    Netzer R, Bischoff U, Ebneth A.
    Curr Opin Drug Discov Devel; 2003 Jul 01; 6(4):462-9. PubMed ID: 12951809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.